Skip to content

PEARL Intervention to Reduce Depression Among Adults With Epilepsy

PEARL Intervention to Reduce Depression Among Adults With Epilepsy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00459329
Acronym
PEARL
Enrollment
80
Registered
2007-04-11
Start date
2007-03-31
Completion date
2009-03-31
Last updated
2008-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Epilepsy

Keywords

Depression, Epilepsy, Problem-Solving Therapy, Mental Health, Neurology, Home-based health care, Community-based program, Collaborative care

Brief summary

The purpose of this study is to test the effectiveness of a home-based depression treatment intervention called Program to Encourage Active, Rewarding Lives (PEARL). We hypothesize that over a 12-month period, compared to usual care, those receiving the PEARL intervention will show more improvement with their depression, have higher quality of life and function, and use fewer medical services.

Detailed description

Compared to non-depressed individuals with epilepsy, those with depression have significantly higher rates of suicide, lower social and occupational functioning, decreased quality of life independent of seizure frequency, and higher non-psychiatric health care utilization. Adults with epilepsy are more likely to be homebound as a result of reduced function and restrictions in driving, opportunities to obtain enhanced quality of care for depression may be limited. This study tests the effectiveness of a home-based multi-modal depression treatment intervention called Program to Encourage Active, Rewarding Lives (PEARL). PEARL consists of problem solving treatment, social and physical activation, pleasant events scheduling, support and education regarding antidepressant medication use as well as psychiatric consultation and recommendations regarding initiation or adjustment of antidepressant medications. In a sample of adults with epilepsy who have minor depression, major depression and/or dysthymia, we hypothesize that over a 12-month period, compared to usual care, those randomized to the PEARL intervention will: achieve higher levels of depression response and remission, achieve higher quality of life and function, and utilize less non-psychiatric health care. By providing a multi-modal, home-based stepped collaborative care intervention for adults with depression and epilepsy, this program will offer practical alternatives to usual care and will provide a program for improving depression outcomes, quality of life and potentially, epilepsy outcomes.

Interventions

BEHAVIORALProgram to Encourage Active, Rewarding Lives (PEARL)

Eight 50-minute in-home sessions over 19 weeks with a masters-level social work counselor using Problem Solving Therapy (PST). PST is a skills-enhancing behavioral depression treatment based on the assumption that an accumulation of problems in living cause and maintain depressive symptoms, and through systematically identifying and addressing these problems, patients achieve decreased depressive symptoms. Counselors also help participants to increase social and physical activities and to incorporate pleasant activities into patients' lives. Counselors provide education and monitoring for antidepressant use, and work with the participant's physician and PEARL psychiatrist to recommend initiating or adjusting antidepressant medications. The PHQ-9 is administered at each session to track depression change. After 19 weeks, counselors will maintain monthly telephone calls with participants, administering the PHQ-9 and assessing PST success.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Home address within 30 miles of Seattle * Diagnosis of epilepsy (ICD-9 code 345.XX) * Appointment in the UW REC or Neurology clinic in the past 2 years and currently enrolled in this clinic. * Current age older than 18 years * Diagnosis of major depression, minor depression or dysthymia * Ability to speak/read English

Exclusion criteria

* Alcohol and/or substance abuse/dependence based on a score greater than 1 on 4-item validated CAGE-AID * Cognitive impairment based on a score less than 3 on a 6-item validated cognitive screen * Diagnosis of bipolar disorder, schizophrenia/schizoaffective disorder or other psychotic disorder * Women who are pregnant or nursing * Terminal medical illness * Those currently seeing or planning to see a psychiatrist * Those with suicidal ideation nearly every day

Design outcomes

Primary

MeasureTime frame
Mean SCL-20 depression scores6 & 12 months post-baseline
Depression treatment response, defined as greater than 50% decrease in SCL-20 score from baseline6 & 12 months post-baseline
Complete depression remission defined as SCL-20 score less than 0.5.6 & 12 months post-baseline

Secondary

MeasureTime frame
Satisfaction with epilepsy health care6 & 12 months post-baseline
Quality of Life6 & 12 months post-baseline
Epilepsy Self-Efficacy6 & 12 months post-baseline
Pharmaceutical and health care utilization and costs6 & 12 months post-baseline
Seizure frequency and severity6 & 12 months post-baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026